The company will collaborate with Duke on cancer biomarker discoveries, and intends to use and commercialize the markers through agreements with drug developers.
The NC-based startup is led by a former LabCorp executive and is seeking partnerships to bring molecular diagnostic products to market.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
The Wall Street Journal looks into the cost of new gene therapies.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.